Name | Number of supported studies | Average coverage | |
---|---|---|---|
retinal pigment epithelial cell | 3 studies | 47% ± 20% |
Insufficient scRNA-seq data for expression of KCNJ13 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 74% | 41.02 | 1344 / 1809 | 56% | 7.19 | 263 / 472 |
thymus | 95% | 61.59 | 623 / 653 | 28% | 1.12 | 168 / 605 |
kidney | 98% | 66.04 | 87 / 89 | 21% | 1.77 | 192 / 901 |
eye | 0% | 0 | 0 / 0 | 98% | 18.55 | 78 / 80 |
stomach | 77% | 61.34 | 278 / 359 | 7% | 0.48 | 21 / 286 |
ovary | 59% | 7.02 | 107 / 180 | 6% | 0.22 | 26 / 430 |
breast | 53% | 8.75 | 244 / 459 | 4% | 0.21 | 41 / 1118 |
brain | 54% | 19.36 | 1427 / 2642 | 2% | 0.14 | 11 / 705 |
pancreas | 45% | 4.59 | 149 / 328 | 4% | 0.12 | 7 / 178 |
bladder | 43% | 5.19 | 9 / 21 | 5% | 0.33 | 26 / 504 |
intestine | 40% | 396.37 | 387 / 966 | 4% | 0.14 | 20 / 527 |
prostate | 42% | 5.22 | 102 / 245 | 1% | 0.05 | 5 / 502 |
uterus | 38% | 4.29 | 65 / 170 | 1% | 0.05 | 5 / 459 |
lung | 35% | 3.67 | 200 / 578 | 3% | 0.26 | 36 / 1155 |
adipose | 38% | 4.48 | 453 / 1204 | 0% | 0 | 0 / 0 |
esophagus | 19% | 1.84 | 268 / 1445 | 6% | 0.19 | 11 / 183 |
liver | 20% | 1.86 | 46 / 226 | 2% | 0.46 | 8 / 406 |
blood vessel | 20% | 2.25 | 266 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 19% | 1.53 | 48 / 258 | 0% | 0 | 0 / 230 |
spleen | 17% | 1.59 | 41 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 14% | 1.45 | 134 / 929 | 0% | 0 | 0 / 0 |
heart | 12% | 1.05 | 107 / 861 | 0% | 0 | 0 / 0 |
muscle | 10% | 0.85 | 82 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0034765 | Biological process | regulation of monoatomic ion transmembrane transport |
GO_0006813 | Biological process | potassium ion transport |
GO_1990573 | Biological process | potassium ion import across plasma membrane |
GO_0034702 | Cellular component | monoatomic ion channel complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0005242 | Molecular function | inward rectifier potassium channel activity |
Gene name | KCNJ13 |
Protein name | Potassium inwardly rectifying channel subfamily J member 13 Inward rectifier potassium channel 13 (Inward rectifier K(+) channel Kir7.1) (Potassium channel, inwardly rectifying subfamily J member 13) |
Synonyms | |
Description | FUNCTION: Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages. The inward rectification is mainly due to the blockage of outward current by internal magnesium. KCNJ13 has a very low single channel conductance, low sensitivity to block by external barium and cesium, and no dependence of its inward rectification properties on the internal blocking particle magnesium. |
Accessions | H7C4D1 O60928 ENST00000438786.1 C9JWD6 ENST00000410029.1 [O60928-1] ENST00000409779.1 [O60928-2] ENST00000233826.4 [O60928-1] ENST00000444142.1 |